FDA official logo
GSRS logoPFDA official logo

ACTINIUM AC-225 ALPITATUG SATETRAXETAN

UNII:DP81KW1394
Type:INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:ACTINIUM AC-225 ALPITATUG SATETRAXETAN
GSRS Full Record:
DP81KW1394
i

  • 2921676-06-2
  • ACTINIUM AC 225 ALPITATUG SATETRAXETAN [USAN]
  • Actinium (<sup>225</sup> Ac) Alpitatug Satetraxetan
  • Actinium Ac-225 Alpitatug Satetraxetan
  • Actinium Alpitatug Satetraxetan Ac-225
  • Alpitatug Satetraxetan Actinium Ac-225
  • Immunoglobulin G1, anti-(human kallikrein 2) (human-Mus musculus monoclonal KL2B1 allotype G1m(17) γ1-chain), disulfide with human-Mus musculus monoclonal KL2B1 κ-chain, dimer, N<sup>6</sup>-[[[4-[[1,4,7,10-tetrakis[(carboxy-κO)methyl]-1,4,7,10-tetr...
  • Immunoglobulin G1-kappa, anti-[Homo sapiens KLK2 (kallikrein-2, kallikrein peptidase 2, kallikrein 2 prostatic)], humanized monoclonal antibody; H-gamma1 heavy chain humanized (1-447) [VH (Homo sapiens IGHV4-28*01 (90.7%) -(IGHD) -IGHJ1*01 (100%), CDR-IMGT [9.7.10] (26-34.52-58.97-106)) (1-117) -Homo sapiens IGHG1*03v (100%) G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14 (CH1 R120>K (214) (118-215), hinge 1-15 (216-230), CH2 (231-340), CH3 E12 (356), M14 (358) (341-445), CHS (446-447)) (118-447)], (220-218')-disulfide with L-kappa light chain humanized (1'-218') [V-KAPPA (Homo sapiens IGKV4-1*01 (81.2%) -IGKJ2*01 (100%), CDR-IMGT [10.3.9] (27'-36'.54'-56'.93'-101')) (1'-111') - Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (157'), V101 (195')) (112'-218')]; dimer (226-226'':229-229'')- bisdisulfide, produced in Chinese hamster ovary (CHO) cells, glycoform alfa; conjugated via the side chain nitrogen of an average of 3 lysine residues to actinium (225Ac) radiolabeled rac-(4-{[(2R)-1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecan-2-yl]methyl}phenyl)carbamothioyl (satetraxetan)
  • JNJ-69086420 (225Ac DOTA-h11B6)
  • KL2B1.D.AC
  • actinium (<sup>225</sup> Ac) alpitatug satetraxetan [INN]




UNII - DP81KW1394 | UNII Search Service